Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Identify Clinical Conditions That Increase Circulating DNA Levels (BARDA II)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01815996
First received: March 12, 2013
Last updated: July 26, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)